Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Multiple Myeloma × Panobinostat × Clear all

Phase

Status

Completed 21 Terminated 6 Withdrawn 2 No longer available 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 2 Primary Myelofibrosis 1 Polycythemia Vera 1 Nasopharyngeal Carcinoma 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Hereditary Sensory and Autonomic Neuropathies 1 Chordoma 1 Advanced Solid Tumors 1

Interventions

Dexamethasone 61 Cyclophosphamide 40 Bortezomib 35 Melphalan 22 Lenalidomide 21 Thalidomide 17 pomalidomide 15 fludarabine 12 daratumumab 10 carfilzomib 9 Doxorubicin 8 Filgrastim 7 Busulfan 6 Prednisone 5 Peripheral Blood Stem Cell Transplantation 5 Bendamustine Hydrochloride 5 selinexor 4 sargramostim 4 ixazomib 4 fludarabine phosphate 4 Surveys and Questionnaires 4 Mycophenolic Acid 4 Etoposide 4 Clarithromycin 4 Calcium Dobesilate 4 liposomal doxorubicin 3 isatuximab 3 Radiotherapy 3 Neoadjuvant Therapy 3 Methylprednisolone 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02145715 2015-06-26

MUKsix

University of Leeds

Phase 1/2 Unknown

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡